Coda Biotherapeutics   Report issue

For profit Phase 2
Founded: South San Francisco CA United States (2014)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CODA, Inc Research Department

Active Ingredients

Drugs in Phase 2 Trials (1)

Key: Coda Biotherapeutics (0) Acquired (1)

bradanicline (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1